Scientific Sessions
The Genetics of Pulmonary Hypertension
June 21-22, 2012
At the Scientific Sessions at PHA's 10th International PH Conference, researchers and medical providers will have the opportunity to engage in educational sessions about PH practice and cutting-edge research. This year's topic, The Genetics of Pulmonary Hypertension, features PH experts who will share their experience and understanding of heredity in the field. The Scientific Sessions will also feature a robust presentation of abstract posters, and free-form panel discussions about the top abstracts.
Learning Objectives
After participating in this activity, participants will be able to:
- Describe the diseases recognized as having a heritable etiology of Pulmonary Hypertension and the genes involved.
- Describe the role of bone morphogenic protein receptor 2 (BMPR2) in the pathobiology of PAH and its pathway as a potential therapeutic target.
- Discuss the contribution of epigenetic modications in the pathobiology of PAH.
Scientific Sessions Schedule and Speakers
Scientific Sessions and PH Clinicians and Researchers Dinner Forum
Thursday, June 21, 6-8 p.m.
The Global Spectrum of Pulmonary Hypertension and its Forgotten Impact in the Developing World
Ghazwan Butrous, MB, ChB, PhD
Pulmonary Vascular Research Institute, United Kingdom
Scientific Sessions: The Genetics of Pulmonary Hypertension
Friday, June 22, 7 a.m. - 6 p.m.
Chasing Pulmonary Hypertension: What Have We Caught?
John Newman, MD
Vanderbilt University, Nashville, Tenn.
Pulmonary Arterial Hypertension as a Systemic Disease
James West, PhD
Vanderbilt University, Nashville, Tenn.
Understanding the Molecular Origin of Pulmonary Hypertension: Role of MicroRNAs
Sebastien Bonnet, PhD
Laval University, Quebec City, Canada
Update from the NHLBI's Lung Vascular Research Program
Timothy Moore, MD, PhD
National Institutes of Health, Bethesda, Md.
Pathogenesis of Pulmonary Arterial Hypertension: Clues from Patients and Animal Models of Hereditary Hemorrhagic Telangiectasia
Mourad Toporsian, PhD
Harvard Medical School, Boston, Mass.
Rescuing the BMPR2 Pathway, Where Can We Intervene?
Marlene Rabinovitch, MD
Stanford School of Medicine, Stanford, Calif.